Gamma-hydroxybutyric acid has been proposed as a pharmacotherapy for alcoholism in part based on similar discriminative stimulus effects as ethanol. To date, drug discrimination studies with c-hydroxybutyric acid and ethanol have exclusively used rodents or pigeons as subjects. To evaluate possible differences between species, sex, and route of administration, this study investigated the substitution of c-hydroxybutyric acid (intragastrically or intramuscularly) for ethanol 30 or 60 min after administration in male (n = 6) and female (n = 7) cynomolgus monkeys trained to discriminate 1.0 and 2.0 g/kg ethanol. At least one dose of c-hydroxybutyric acid completely or partially substituted for ethanol in three of the 13 monkeys tested, with each case occurring in female monkeys. Ethanol-appropriate responding did not increase with c-hydroxybutyric acid dose. Monkeys were more sensitive to the response rate decreasing effects of c-hydroxybutyric acid administered intramuscularly compared with intragastrically. The lack of c-hydroxybutyric acid substitution for ethanol suggests that these drugs have different receptor bases for discrimination. Furthermore, the data do not strongly support shared discriminative stimulus effects as the rationale for c-hydroxybutyric acid pharmacotherapy for alcoholism.
Introduction
Gamma-hydroxybutyric acid (GHB) is a recreationally abused drug that is also used to treat insomnia (Pardi and Black, 2006) . Like ethanol, GHB produces sedation, anesthesia (Cash, 1994) , anxiolysis (Schmidt-Mutter et al., 1998; Gessa et al., 2000) , ataxia, and hypothermia (Nicholson and Balster, 2001) . Ethanol and GHB are frequently coabused. In one study, 64% of the cases of GHB abuse reported in emergency rooms involved ethanol consumption (Drug Abuse Warning Network, 2002; Ricuarte and McCann, 2005) . The apparent similarity between the effects of GHB and ethanol has prompted the assessment of GHB as a treatment for alcoholism (Addolorato et al., 1996) . Endogenous GHB is a neuromodulator released in a Ca 2 + -dependent manner, a minor metabolite of g-aminobutyric acid (GABA), and product of 1,4-butanediol and g-butyrolactone (Nicholson and Balster, 2001) . Peripherally administered GHB crosses the blood-brain barrier and its effects are mediated by GABA B (Lingenhoehl et al., 1999) and GHB receptors (Andriamampandry et al., 2003 (Andriamampandry et al., , 2006 . In humans, GHB reduces craving for ethanol (Di Bello et al., 1995) , ethanol consumption (Gallimberti et al., 2000) , and ethanol withdrawal symptoms (Nimmerrichter et al., 2002) . Some researchers have argued that the effectiveness of GHB in treating alcoholism is because of similar subjective effects of ethanol and GHB Gessa et al., 2000) .
Drug discrimination is a highly sensitive and pharmacologically specific in-vivo assay for the receptor mechanisms mediating the effects of drugs that individuals can detect and be trained to respond to differentially. These drug effects therefore act as discriminative stimuli (Colpaert, 1986; Holtzman, 1990) . Discriminative stimulus effects are believed to reflect the subjective effects of a drug. Although they are clearly dissociable (Kelly et al., 2003) , 'subjective effects' and 'discriminative stimulus effects' are often used synonymously. In monkeys, drugs that positively modulate GABA A receptors completely substitute for ethanol (e.g. barbiturates, benzodiazepines: Grant et al., 2000;  3a-hydroxy neuroactive steroids: Grant et al., 1996; Bowen et al., 1999) . In monkeys trained to discriminate 1.0 g/kg ethanol from water, ethanol and pentobarbital substituted more potently compared with monkeys trained to discriminate 2.0 g/kg ethanol (Grant et al., 2000) . In addition, antagonists of N-methyl-Daspartate (NMDA) receptors (ketamine, phencyclidine, dizocilpine) substitute for ethanol, albeit in a smaller proportion of the population (Vivian et al., 2002) . Specifically, dizocilpine, phencyclidine, and ketamine showed reduced efficacy to substitute for 2.0 g/kg ethanol, especially in male monkeys, compared with male monkeys trained to discriminate 1.0 g/kg ethanol or female monkeys trained to discriminate 1.0 or 2.0 g/kg ethanol (Vivian et al., 2002) . In contrast, neither the GABA A agonist muscimol nor the m-opioid receptor agonist morphine substituted for ethanol (Grant et al., 2000) . Thus, GABA A receptor positive modulators, but not GABA A agonists, and noncompetitive NMDA receptor antagonists produce ethanol-like discriminative stimulus effects when administered systemically. Pregnenolone, progesterone, and their metabolites that positively modulate GABA A receptors are increased in the cortex and hippocampus of rats injected with 150-300 mg/kg GHB [(intraperitoneally (i.p.) ] (Barbaccia et al., 2002) . These metabolites include the steroid 3a-hydroxy-5a-pregnan-20-one (allopregnanolone), which substitutes for ethanol in cynomolgus monkeys (Grant et al., 1996) . Furthermore, GHB potentiates GABA Amediated inhibitory postsynaptic currents as a result of increased neuroactive steroid biosynthesis in CA1 pyramidal neurons (Sanna et al., 2004) . These data suggest that GHB may substitute for the discriminative stimulus effects of ethanol because of its steroidogenic properties.
Generally, however, GHB does not substitute for ethanol and ethanol does not substitute for GHB in drug discrimination studies, suggesting that the discriminative stimulus effects of GHB and ethanol are distinct (Nicholson and Balster, 2001) . In female rats trained to discriminate 200 mg/kg GHB (i.p.) from saline, ethanol (630-1260 mg/kg) produced little or no substitution (Winter, 1981) . Ethanol (2.5 g/kg, i.p.) only partially substituted for 100 mg/kg GHB (subcutaneously) in male mice (Cook et al., 2006) . Symmetrical generalization between the discriminative stimulus effects of GHB and ethanol was, however, observed within a narrow dose range. Specifically, 1.0 g/kg [intragastrically (i.g.)] ethanol completely substituted in male rats trained to discriminate 300 mg/kg (i.g.) GHB, and vice versa. Symmetrical generalization was not observed with 2.0 g/kg ethanol (Colombo et al., 1995) , suggesting that GHB may share discriminative stimulus only with lower training doses of ethanol. Using the same training doses, Metcalf et al. (2001) reported partial symmetrical generalization between 300-900 mg/kg GHB (i.g.) and 1.0 g/kg ethanol (i.g.) in male rats using a two-lever procedure in contrast to the t-maze used by Colombo et al. (1995) . Recently, however, 1.0-4.0 g/kg ethanol at most partially substituted for 300 mg/kg (i.g. or i.p.) GHB in rats (Baker et al., 2004 (Baker et al., , 2005 . A low dose of GHB that produces waterappropriate responding alone did not increase sensitivity to the discriminative stimulus effects of ethanol in male mice (Cook et al., 2006) , nor did GHB alter ethanol reinforcement in rhesus monkeys (Winger et al., 2007) . These findings suggest that GHB and ethanol have nonadditive receptor mechanisms that overlap to a very limited extent. Furthermore, the discriminative stimulus effects of GHB seem to be influenced by whether water or food is used to train the discrimination. When rats are water-deprived and trained to discriminate 300 mg/kg GHB (i.g.) with water reinforcement, i.p. administration of GHB does not substitute. In contrast, i.g. or i.p. GHB partially substitutes for GHB (i.g.) in food-deprived, foodreinforced rats (Baker et al., 2004) . Overall, the data from drug discrimination studies suggest a limited pharmacological basis for the similarity of GHB and ethanol. The apparent coabuse of these substances by humans and the proposal that GHB can be an effective alcoholism pharmacotherapy, however, suggests that primates may show greater overlap between the receptor mechanisms mediating GHB and ethanol compared with rodents. To address this, this study evaluated the ethanol-like discriminative stimulus effects of GHB [(i.g. or intramuscularly (i.m.)] 30 or 60 min after administration in male and female cynomolgus monkeys trained to discriminate 1.0 or 2.0 g/kg ethanol (i.g.), as the potency of test drugs to substitute for ethanol has been shown to vary with these training doses (Grant et al., 2000; Vivian et al., 2002) .
Methods

Subjects
Male (n = 6, 4.9-7.1 kg) and female (n = 7, 2.9-5.1 kg) adult cynomolgus monkeys (Macaca fascicularis) were housed in a temperature-(23 ± 11C) and humidity-(40-60%) controlled room with a 12-h light-dark cycle (lights on, 06 : 00 h). Stainless steel cages (76 Â60 Â70 cm) were modified for social housing. For training and feeding (3-4 h), the monkeys were housed individually. At all other times, the monkeys were housed in groups of two, three, or four. The monkeys were fed with nutritionally complete diet (Purina Mills, St Louis, Missouri, USA), daily fruit supplements, and the food delivered during experimental sessions. Water was available freely except during operant training and testing. Grant et al. (1996 Grant et al. ( , 2000 describe the monkeys' origin and housing conditions. These studies were conducted according to the guidelines of the Wake Forest University Animal Care and Use Committee and the Guidelines of the Committee on the Care and Use of Laboratory Animal Resources (NRC 1996) .
Apparatus
Experimental sessions took place 5-6 days per week in ventilated and sound-attenuating chambers (1.50 Â 0.74 Â 0.76 m; Med Associates, Inc., St Albans, Vermont, USA) designed to accommodate a primate chair (1.17 Â 0.61 Â 0.61 m; Plas Labs, Lansing, Michigan, USA). A panel (0.48 Â 0.69 m) was mounted on one wall of the chamber within arm's reach of a monkey sitting in a primate chair. The panel contained two retractable levers, three lights (amber, green, and red) above each lever, and a central white light. Two house lights were located near the ceiling at the rear of the chamber. A food tray was attached to the primate chair to receive 1-g bananaflavored pellets (P.J. Noyes, Lancaster, New Hampshire, USA). The pellets were delivered through vinyl tubing connected to a feeder set outside of the chamber. The scheduling of events and data acquisition was controlled by a PC-compatible or Macintosh-compatible computer connected to an interface (Med Associates, St Albans, Vermont, USA) programmed with LabView software (National Instruments, Austin, Texas, USA).
Procedure
Experimental design
The experiment consisted of four groups of monkeys in a 2 Â 2 experimental design with sex and ethanol training dose as the main group factors. Discrimination training with 1.0 g/kg ethanol (20% w/v, 5 ml/kg) versus water was conducted with three male (4864, 4865, 4867) and four female (2830, 2852, 2913, 3123) monkeys. Discrimination training with 2.0 g/kg ethanol (20% w/v, 5 ml/kg) versus water was conducted with three male (4890, 4891, 4889) and three female (2835, 3220, 5999) monkeys.
Discrimination training
For each session, the monkey was seated in a primate chair that was wheeled into the chamber. The number of responses per reinforcer was increased from fixed ratio (FR)-1 to a terminal schedule of FR-15-100. The terminal FR was set for each monkey so that all the pellets were delivered in approximately 5 min, with males receiving 20-25 pellets and females receiving 10-15 pellets per session. The duration over which behavior was measured was limited to minimize variability in brain concentrations of ethanol and GHB. A session ended after all the pellets were delivered or 30 min, whichever occurred first. Response training was complete after responding under the terminal FR schedule and was stable with more than 0.25 responses/s for three consecutive sessions. After response training, the monkeys were habituated to nasogastric (i.g.) gavage in which an infant feeding tube (5 French, 1.7 Â 381 mm) was passed down one nostril, through the esophagus and into the stomach. For five consecutive sessions, the monkeys received tap water (5 ml/kg, i.g.), were wheeled into the chamber, and after a pretreatment time of 30 min, the 'water-appropriate' lever extended into the chamber coinciding with illumination of the lights above the lever. The next five sessions were identical, except the monkeys were administered a training dose of ethanol (1.0 or 2.0 g/kg, i.g.) and reinforced for responding on the 'ethanolappropriate' lever. After the 30-min pretreatment time, the house and center lights were illuminated and the appropriate lever extended into the chamber. Completion of a FR requirement resulted in the center light shutting off, immediate delivery of a banana pellet, and then reillumination of the center light (less than 1 s).
Discrimination training commenced after these 10 sessions. For discrimination training sessions, either ethanol or water was administered, and after 30 min, both sets of lights above the levers illuminated and both the water-appropriate and ethanol-appropriate levers extended into the chamber. Completion of consecutive responses on the appropriate lever satisfying the FR requirement resulted in delivery of a banana pellet. Responses on the inappropriate lever set the response count on the appropriate lever to zero. Ethanol and water training sessions alternated after two sessions with either condition (i.e. ethanol, ethanol, water, water). The training session condition was changed, however, if more than or equal to 90% of the responses during the entire session and more than or equal to 70% during the first FR were on the appropriate lever. Discrimination training was complete when these accuracy criteria were satisfied for five consecutive sessions.
Substitution testing
Substitution tests were conducted twice per week. A single dose of GHB (0, 30, 56, 100, 170, 300, 560 mg/kg, i.m. or i.g.) was administered 30 or 60 min before the water-appropriate and ethanol-appropriate levers were extended into the chambers. The doses were selected to encompass the range of doses trained or tested in earlier studies and the doses of GHB that increase hippocampal and cortical neuroactive steroids (see Introduction). Consecutive responses satisfying the FR requirement on either lever resulted in reinforcement during test sessions. If the monkey switched levers, however, the response count for the other lever was set to zero.
Training sessions intervened between test sessions. If the accuracy criteria were not met during a training session, training continued until the criteria were met for three consecutive sessions. Each test drug dose was usually administered both after an ethanol training session and after a water training session. The range of test doses was selected for each monkey to include a minimal dose that did not alter rates of responding or substitute for ethanol and a maximal dose that decreased response rates by more than or equal to 50% from the preceding training session. Typically, the order of doses tested began in the middle of the dose range. An equal distribution of higher and lower doses was subsequently tested. The maximum dose of i.m. GHB tested was limited to the injection volume tolerated by the monkey and sedation. Higher doses were not tested if the monkey seemed to be in pain during an injection (e.g. grimace) or did not consume a full meal the next day.
g-hydroxybutyrate (sodium salt) (GHB; Sigma, St Louis, Missouri, USA) was dissolved in saline and administered in i.m. injection volumes of less than or equal to 2 ml/kg and i.g. infusion volumes of 3-5 ml/kg after a flush with 5 ml water. All drug doses were based on the salt form. Large i.m. volumes were administered with multiple injections (up to three), limiting the maximum dose tested because of tolerability. Vehicle was tested with equivalent volumes administered to matched i.m. injection sites. All drugs were prepared fresh daily.
Data analysis
For each monkey and test session, the percentage of total responding on the ethanol-appropriate lever (total responses on the ethanol-appropriate lever/total responses), and response rate (total responses/session time) was calculated. When ethanol-appropriate responding was double determined, ethanol-appropriate responding was averaged from the values obtained after both the ethanol and water training sessions. Complete and partial substitution was operationally defined as, respectively, more than or equal to 80% and more than or equal to 20-79% of the responses on the ethanol-appropriate lever. Baseline response rate was calculated by averaging the response rates for each ethanol and water training session immediately preceding a test session. Response rates were analyzed with 2 (sex) Â 2 (training dose) mixedfactor analysis of variances (ANOVAs) with route of administration (i.g., i.m.) as a within-monkeys factor. Percent of baseline response rate and percent ethanolappropriate responding were analyzed with 2 (sex) Â 2 (training dose) Â3 (GHB dose) Â2 (pretreatment interval) mixed factor repeated measures ANOVAs with GHB dose and pretreatment interval as within-monkeys factors. The dose at which response rate was decreased by 50% from baseline (ED 50 ) was computed via linear interpolation between the two doses that encompassed the 50% effect. When a drug completely substituted for ethanol, the ED 50 was computed. Huynh-Feldt corrections were used for analyses with repeated factors violating the sphericity assumption (adjusted degrees of freedom are cited throughout the manuscript). Main effects and interactions were evaluated with Bonferroni-corrected pairwise comparisons. For all tests, a was 0.05.
Results
Percentage of ethanol-appropriate responding did not increase with GHB dose after i.m. [F(3,12) = 0.52] or i.g.
[F(1.61,11.29) = 0.08] administration. No main effects or interactions involving sex, pretreatment interval, or training dose for percentage of ethanol-appropriate responding after i.m. or i.g. GHB were present. Complete substitution of GHB for ethanol was observed in one case: after a 60-min pretreatment, in a female trained to discriminate 1.0 g/kg ethanol (3123), the ED 50 for GHB substitution was 92.8 mg/kg (i.g.) (98% ethanol-appro-priate responding). Three cases of partial substitution were observed in female monkeys, two after i.g. GHB (Fig. 1) and one after i.m. GHB (Fig. 2) . No cases of complete or partial substitution of GHB for ethanol in male monkeys (Figs 3 and 4) .
A 2 (sex) Â 2 (training dose) Â 2 (route: i.m., i.g.) mixed factor repeated measures ANOVA indicated that the baseline response rates during sessions preceding tests with i.m. and i.g. GHB did not significantly differ. Although males had slightly lower response rates, mean baseline response rate in sessions preceding GHB given i.m. did not differ significantly between the sex or training dose groups (1.0 g/kg: female, 2.3 ± 0.6; male, 1.8 ± 0.6; 2.0 g/kg: female, 2.4 ± 0.6; male, 1.2 ± 0.6 responses/s). The same result was obtained when rates during the sessions preceding i.g. GHB were analyzed (1.0 g/kg: female, 2.5 ± 0.4; male, 1.8 ± 0.4; 2.0 g/kg: female, 1.6 ± 0.5; male, 1.1 ± 0.6 responses/s). Vehicle treatment decreased rates of responding below 100% of baseline in six out of 12 cases with i.g. vehicle across both pretreatment intervals, with mean ( ± SEM) percent of baseline response rate 65.8 ± 9.3 for these six cases. Intramuscular vehicle injections decreased response rates to 61.9 ± 8.3% of baseline in the seven out of 15 cases in which rates of responding were less than 100% including both pretreatment intervals. Overall, vehicle treatments did not systematically affect rates of responding.
Percentage of baseline response rates decreased significantly with GHB dose after i.m. [F(3,6) = 6.2, P r 0.05] but not i.g. [F(2,14) = 0.6] administration. Examination of Figs 1-4 , however, reveals that rates of responding decreased from baseline in a majority of monkeys after i.g. GHB, with decreases to less than or equal to 50% of baseline response rate in seven out of 24 (29%) monkeys across both pretreatment intervals. Intramuscular GHB showed slightly greater efficacy to reduce response rates, with six out of 16 (37.5%) showing response rates lesser than or equal to 50% across both pretreatment intervals (Table 1) . No significant interactions among the factors were present. With GHB given i.m., the overall percentage of baseline response rate was more than 90% for zero, 170, and 300 mg/kg, but declined to 53.3 ± 23.8% after 560 mg/kg GHB (i.m.). Females trained to discriminate 2.0 g/kg ethanol and males trained to discriminate 1.0 g/kg ethanol were not tested with 0 mg/kg GHB (i.g.), so the earlier analysis excluded this dose. A subsequent analysis included only the groups for which 0 mg/kg GHB (i.g.)
was tested, that is, females trained to discriminate 1.0 g/kg ethanol and males trained to discriminate 2.0 g/ kg ethanol. A 2 (sex) Â2 (training dose) Â4 (dose: 0, 170, 300, 560 mg/kg) mixed factor ANOVA with dose as the within-subjects factor did not reveal a main effect of dose [F(1.77, 7.07) = 0.74] on percent of baseline response rate after i.g. GHB. Overall, both i.g. and i.m. GHB decreased response rates albeit somewhat nonsystematically and with moderate individual differences.
Discussion
This study found little evidence that the discriminative stimulus effects of pharmacologically active doses of GHB (i.g. or i.m.) are similar to those of 1.0 or 2.0 g/kg ethanol (i.g.). All cases of complete or partial substitution occurred at submaximal doses. Some monkeys showed dose-dependent decreases in response rate indicating that the doses tested were pharmacologically active, although these doses did not substitute for ethanol. The lack of dose-dependent substitution of GHB for ethanol in this study is consistent with past drug discrimination studies reporting that GABA A receptor positive modulators and NMDA receptor antagonists, at best, partially substitute for GHB in rats (Colombo et al., 1998; Baker Percentage of ethanol-appropriate responding and percentage of decrease in response rate (RR) from baseline in individual female cynomolgus monkeys trained to discriminate 2.0 g/kg ethanol from water with a 30-min pretreatment interval 30 min or 60 min after administration of g-hydroxybutyric acid (GHB) [intragastrically (i.g.) or intramuscularly (i.m.)]. Intragastric vehicle treatments were not tested. Data points may overlap. 
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Percentage of ethanol-appropriate responding and percentage of decrease in response rate (RR) from baseline in individual male cynomolgus monkeys trained to discriminate 1.0 g/kg ethanol from water with a 30-min pretreatment interval 30 min or 60 min after administration of g-hydroxybutyric acid (GHB) [intragastrically (i.g.) or intramuscularly (i.m.)]. Intragastric vehicle treatments were not tested. Data points may overlap.
GHB substitution for ethanol in monkeys Helms et al. 321 et al., 2004 Helms et al. 321 et al., , 2005 or pigeons (Koek et al., 2004) . In contrast, the results of this study differ from the report that 300 mg/kg GHB and 1.0 g/kg ethanol show complete symmetrical generalization (Colombo et al., 1995) . In this study, 300 mg/kg (i.g.) GHB partially substituted for 1.0 g/kg ethanol in only one monkey tested (Fig. 1) . Indeed, rats can be trained to discriminate between 300 mg/kg (i.g.) GHB and 1.0 or 1.5 g/kg (i.g.) ethanol, suggesting dissociable discriminative stimulus effects (Baker et al., 2008) . The discriminative stimulus effects of GHB seem to be mediated by agonism of GABA B and GHB receptors (e.g. Lobina et al., 1999; Carter et al., 2003; Carai et al., 2004; Baker et al., 2005) .
The few cases of complete or partial substitution of GHB for ethanol occurred in female monkeys. For example, in monkey 3123, 170 mg/kg GHB (i.g.) completely substituted for 1.0 g/kg ethanol (i.g.) (Fig. 1 ). In this case, the dose of GHB is low compared to the complete substitution of 300 mg/kg GHB (i.g.) in male rats trained to discriminate 1.0 g/kg ethanol (i.g.) (Colombo et al., 1995) . A female-specific factor, for example, menstrual cyclicity, may influence the substitution of GHB for ethanol. During the luteal phase of their menstrual cycle, when circulating progesterone peaks, cynomolgus monkeys are more sensitive to the discriminative stimulus effects of ethanol, and to the ethanol-like stimulus effects of allopregnanolone, compared with during their follicular phase (low circulating progesterone) . These findings suggest the possibility of additive ethanol-like effects of ovarian-derived and GHBinduced neuroactive steroids. Indeed, the lack of a dosedependent effect of GHB on ethanol-appropriate responding could be accounted for by substitution testing irrespective of menstrual cycle phase. Retrospective evaluation of mense and progesterone records from this set, however, indicates that GHB partially or completely substituted for ethanol during the follicular phase of the menstrual cycle, when circulating progesterone was low or undetectable for monkey 2830 when tested with 300 mg/kg GHB (i.g.) and monkey 3123 when tested with 170 mg/kg GHB (i.g.). It is unlikely, therefore, that the few cases of GHB substitution for ethanol in this study are because of additive effects of neuroactive steroids resulting from GHB administration and luteal phase progesterone derivatives.
The effects of GHB on response rate in this study were influenced by route of administration, with i.m., but not i.g. GHB significantly decreasing rates of responding as a function of dose. With both routes of administration, however, GHB decreased rates of responding with moderate efficacy. The rare tests in which GHB partially or completely substituted for ethanol occurred with both routes of administration. Brain concentrations of GHB could be slightly lower after i.g. compared with i.m. administration because of slower absorption, although this has not yet been investigated. After i.g. administration, GHB is rapidly absorbed through the gastrointestinal The mean ( ± SEM) potency (ED 50 , mg/kg) of GHB to decrease response rate is listed in parentheses where appropriate. GHB, gamma-hydroxybutyric acid; i.g., intragastrically; i.m., intramuscularly.
tract and metabolized in the liver to a greater extent before entering circulation compared with i.m. administration. In general, the discriminative stimulus effects of GHB seem to be independent of route of administration, although route of administration has been shown to interact with reinforcer type. Intragastric GHB only partially substitutes for i.p. GHB in water-reinforced rats (Baker et al., 2004) .
In humans, plasma concentrations of GHB are highly variable from 10 to 360 min after administration of 25 mg/kg GHB (orally), with mean plasma concentrations peaking at 30 min (Brenneisen et al., 2004) . Earlier studies have also reported a lack of or inconsistent decreases in response rate with GHB except with very high doses. For example, 1500 mg/kg (i.g.) GHB decreased response rates in rats (Colombo et al., 1995) . In contrast, Baker et al. (2004) reported minor decreases in rats' response rates after 75-400 mg/kg GHB (i.g.), with the greatest mean percentage of decrease approximating 50%. Percentage of baseline response rate was nearly 50% with up to 300 mg/kg (subcutaneously) GHB in mice (Cook et al., 2006) . Rates of responding were less than or equal to 53% of baseline at 600-900 mg/kg (i.g.) GHB in rats (Metcalf et al., 2001) . In baboons, 350 mg/kg GHB (i.g.) did not disrupt performance of a fine motor task (Weerts et al., 2005) . Indeed, many effects of GHB are characterized by a steep dose-effect function. For example, visual analog scale ratings of 'dizziness' were more than 6-fold greater 90 min after administration of 72 mg/kg GHB (orally) compared with 40 mg/kg GHB, a less than 2-fold dose difference (Abanades et al., 2006) .
The mechanisms accounting for the therapeutic effects of GHB in alcoholics remain speculative. First, GHB may antagonize the discriminative stimulus effects of ethanol.
Antagonists of the discriminative stimulus effects of ethanol, Ro15-4513 and flumazenil (Ro15-1788) (rats: Gatto and Grant, 1997 ; cynomolgus monkeys: Grant, Rogers, and Helms, unpublished observations), partially or completely substituted for GHB in pigeons trained to discriminate 56 or 100 mg/kg GHB (i.m.) (Koek et al., 2006) . Second, GABA B agonism may be important for the therapeutic effects of GHB. The GABA B agonist, baclofen, reduced responding for ethanol in rats (Colombo et al., 2003) and craving in alcoholics (Addolorato et al., 2000) . Baclofen did not, however, antagonize the discriminative stimulus effects of ethanol (Shelton and Balster, 1994) . Third, GHB pharmacotherapy for alcoholism may be mediated by receptor mechanisms that indirectly affect the neural mechanisms mediating ethanol consumption. For example, GHB inhibits dopamine release (e.g. Howard and Feigenbaum, 1997) . Overall, this data provide a convincing demonstration that, in nonhuman primates, GHB does not substitute for the discriminative stimulus effects of ethanol. Thus, the therapeutic effects of GHB in alcoholics is unlikely to be because of substitution for ethanol through a common receptor mechanism.
